Predictors of incident atrial fibrillation and influence of medications: a retrospective case–control study
Authors:
- James A HodgkinsonJHJames A Hodgkinson
- Clare J TaylorCTClare J Taylor
- Fd Richard HobbsFHFd Richard Hobbs
- 1 June 2011
- journal article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 61 (587) , e353-e361
Abstract
Atrial fibrillation (AF) is a common condition, associated with raised mortality and risk of major morbidity, and is predicted to increase due to an aging population. To update earlier research of AF predictors using UK data. Case-control analysis of adults aged 18 years and older with a diagnosis of AF in practices registered with the General Practice Research Database (GPRD) in the UK. Using the GPRD, a case.control analysis was performed using logistic regression to compare 55,412 incident AF cases to 216,400 controls, for medical history and prior use of drugs. The association between time since start of diagnosis or drug use and AF risk was summarised using Spline regression. The following were confirmed as risk factors for AF: heart failure (risk ratio [RR] 2.91 [95% CI = 2.59 to 3.27]); ischaemic heart disease (IHD) (RR 2.00 [95% CI = 1.78 to 2.24]); hypertension (RR 2.60 [95% CI = 2.32 to 2.92]); hyperthyroidism (RR 1.56 [95% CI = 1.39 to 1.75]); being a heavy drinker (RR 1.43 [95% CI = 1.27 to 1.60]); cerebrovascular accident (RR 1.48 [95% CI = 1.32 to 1.66]); and obesity (body mass index ≥30 kg/m(2) RR 1.29 [95% CI = 1.15 to 1.45]). Current use of oral glucocorticoids (RR 1.62 [95% CI = 1.44 to 1.82]) and of beta-2 agonists (RR 1.30 [95% CI = 1.16 to 1.46]) were identified as significant risk factors, and statins (RR 0.82 [95% CI = 0.73 to 0.92]) as a significant protective factor. No effect was found for current use of bisphosphonates (RR 0.95 [95% CI = 0.85 to 1.07]), renin.angiotensin.aldosterone system (RAAS) agents (RR 1.04 [95% CI = 0.93 to 1.17]), or xanthine derivatives (RR 1.09 [95% CI = 0.97 to 1.22]). Spline regression analysis found the effect of heart failure, IHD, use of oral glucocorticoids, and use of statins on the likelihood of developing AF was sustained over a number of years. These findings update the risk factors that are associated with AF, and confirm the protective properties of statins and the risks of beta-2 agonists in developing AF, but not the supposed protective qualities of glucocorticoids and RAAS agents.Keywords
This publication has 61 references indexed in Scilit:
- Effect of β-Blockers on the Risk of Atrial Fibrillation in Patients with Acute Myocardial InfarctionClinics, 2010
- Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studiesBMC Musculoskeletal Disorders, 2009
- The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A systematic reviewJournal of Critical Care, 2009
- Antihypertensive Treatment With ACE Inhibitors or -Blockers and Risk of Incident Atrial Fibrillation in a General Hypertensive PopulationAmerican Journal of Hypertension, 2009
- Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety AnalysisPLOS ONE, 2009
- Bisphosphonates and Atrial FibrillationDrug Safety, 2009
- Use of β2agonists and risk of acute myocardial infarction in patients with hypertensionBritish Journal of Clinical Pharmacology, 2008
- Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trialBMJ, 2007
- Dose-Response and Trend Analysis in EpidemiologyEpidemiology, 1995
- Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)The American Journal of Cardiology, 1994